What are the emerging concerns and threats in relation to overdose deaths? Where have the numbers of drug-induced deaths increased over the last 10 years? How can these deaths be prevented? These are among the questions explored in the EUDA’s ‘Frequently asked questions (FAQs): drug overdose deaths in Europe’, published today ahead of International Overdose Awareness Day (31 August).
Across Europe, overdose is a leading cause of avoidable death among people who use drugs. The European Drug Report 2024 describes how some 6 400 deaths, were reported in the European Union in 2022,…
Čtěte více
The European Union Drugs Agency (EUDA) is teaming up with the Brazilian Secretaria Nacional de Políticas sobre Drogas e Gestão de Ativos (SENAD) this week to host a series of evidence-based prevention events in Brasília. The events aim to strengthen prevention efforts in Latin America by fostering the use of scientifically proven strategies.
The first event is a European Prevention Curriculum (EUPC) basic training course, being delivered in Portuguese to Brazilian prevention experts (27–28 August). The Portuguese version of the course, adapted to the Brazilian context, was a joint initiative…
Čtěte více
What are psychedelic substances? Why are they currently being researched in the medical field? Are psychedelics already available for treatment in Europe? These are some of the issues addressed in a new set of EUDA Frequently Asked Questions (FAQs): therapeutic use of psychedelic substances released today.
The FAQs are published in response to the growing interest in the therapeutic use of psychedelic substances and the need for reliable information on the topic. The digital resource is based on the findings from an EUDA project to develop a better understanding of key developments in this…
Čtěte více
